Rocket Pharmaceuticals Inc. (RCKT)
RCKT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.30
-7.26% on the day
Market cap
$252.5M
Micro cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$223.1M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | RCKT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2015 |
| SEC CIK | 0001281895 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$223.1M |
| Operating income | -$231.7M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $77.6M |
| Total assets | $330.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-03-10 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-10-06 |
| Latest proxy | DEFA14A | 2026-04-06 |
Source: SEC EDGAR submissions feed, 966 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BCYC | Bicycle Therapeutics plc | $3.63 | -4.47% | $254.1M |
| BIOA | BioAge Labs Inc. | $5.57 | -6.23% | $255.6M |
| VOGX | Vogenx Inc | $16.76 | -2.22% | $249.0M |
| ABEO | Abeona Therapeutics Inc. | $4.52 | -7.75% | $258.5M |
| CATX | Perspective Therapeutics Inc. | $2.27 | -9.92% | $259.1M |
| VNDA | Vanda Pharmaceuticals Inc. | $4.30 | -5.29% | $260.0M |
| AMRN | Amarin Corporation plc | $11.58 | +0.43% | $244.6M |
| ACIU | AC Immune SA | $2.40 | -2.04% | $244.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier